胃
癌症
幽门螺杆菌
肺癌
胃癌
抗原
医学
病理
免疫疗法
癌症研究
生物
胃肠病学
内科学
免疫学
作者
Toshikazu Otsuka,Takashi Fukuyama,Nobue Futawatari,Kumiko Tahara,Masaaki Watanabe,Yoshinobu Ichiki,Takafumi Soeno,Yoshihito Takahashi,Hitoshi Yamazaki,Yuma Fujimori,Taichi Ohshiro,Noritada Kobayashi,Mitsuhiro Kida,Wasaburo Koizumi,Chika Kusano
出处
期刊:Journal of Cancer
[Ivyspring International Publisher]
日期:2022-01-01
卷期号:13 (14): 3526-3532
被引量:2
摘要
Background: Kita-Kyushu lung cancer antigen-1 (KK-LC-1), encoded by CT83, is a cancer/testis antigen (CTA) and an attractive target for immunotherapy. Our previous study demonstrated frequent CT83 expression in gastric cancers (GCs) and non-tumor sites of the stomach with tumors. Additionally, there was a correlation with Helicobacter pylori (Hp) infection. Since it currently remains unclear whether KK-LC-1 is expressed in the stomach without GC, this study investigated KK-LC-1 expression in non-GC stomach. Methods: We investigated differences in CT83 gene expression at non-tumor sites of stomachs with or without tumors in 118 GC patients and 115 non-GC patients. Fisher's exact test was used for statistical analyses. Results: CT83 expression was detected in 77% of non-tumor sites in stomachs with tumors, which was significantly higher than in stomachs without tumors (7%, p < 0.0001). All patients with CT83 expression at non-tumor sites of their stomachs without tumors carried Hp. Conclusion: CT83 appears to be rarely expressed in the atrophic stomach, and furthermore, a part of patients positive for its expression will develop GC in the future, suggesting that CT83 expression is a useful marker for predicting GC.
科研通智能强力驱动
Strongly Powered by AbleSci AI